Developing a specific screening assay to detect conformational PLP1-specific Abs in MS patient CSF and serum was challenging due to the reduced sensitivity of live-cell assays and the reduced specificity of purified myelin ELISAs. This evidence concerns the gene PLP1 and myeloid sarcoma.